Download Full 2019 Programme here

Day One: Tuesday 29th January, 2019
0845 Welcome & opening remarks Ian Young
Enhanced Healthcare – improving patient outcomes and accountable care

0900 Outcome based healthcare and laboratory medicine
Mike Hallworth, Consultant Biochemist, Royal Shrewsbury Hospital, Shrewsbury, UK. Worked at pharmaceutical companies to create Propecia

0930 Adding value to healthcare by improved utilisation of laboratory medicine
Gary Procop, Professor of Pathology and Chairman of the Department of Molecular Pathology, Cleveland Clinic, Cleveland, OH, US

1000 Using data to impact change
Bill Morice, President of Mayo Medical Laboratories, Departmental Chair for Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, US

¿Quiere comprar tabletas efervescentes Kamagra?

¿Le gustaría pedir tabletas efervescentes Kamagra? Una declaración simple en la farmacia Kamagra. Después de desarrollar Kamagra en forma de píldora, ahora también han desarrollado las tabletas efervescentes Kamagra. Una tableta efervescente que se parece exactamente a una tableta efervescente de vitaminas. ¡Así que mantén estos dos bien separados!

¿Qué son las tabletas efervescentes de Kamagra?

Las tabletas efervescentes de Kamagra son píldoras para la erección con sildenafil, pero en forma efervescente. Por ejemplo, comprar tabletas efervescentes Kamagra en farmacia es útil cuando desea viajar en avión. Debido a que son tabletas efervescentes, esto se nota menos que cuando toma Kamagra en forma de píldora. Como se puede ver en la foto del producto, los comprimidos efervescentes se envasan en un tubo. Un cartucho contiene 7 comprimidos efervescentes. El sabor que desprenden las tabletas efervescentes es naranja, el mismo sabor que las conocidas tabletas efervescentes de Vitamina C. Al igual que el conocido Kamagra, estos comprimidos también contienen 100 mg de Sildenafil. Esta es la sustancia activa que le da una erección. ¿Todavía no está familiarizado con la sustancia Sildenafil? Lea más sobre este tejido aquí. Otra ventaja en comparación con las píldoras tradicionales de Kamagra es que el cuerpo las absorbe más rápido. Esto significa una erección para tu pareja y para ti más rápido.

Rick VanNess, Director, Product Development, Tricore Reference Laboratories, Albuquerque, New Mexico, US

1100 Break

The Future of the Pathology Workforce
1120 The workforce pressures facing pathology and what are the potential solutions
Jo Martin, President Royal College of Pathologists, UK

1145 Case study- Biomedical Scientist reporting in Cellular Pathology
Gerhard Van Schalkwyk, Consultant Histopathologist and Clinical Director, University Hospitals of Derby and Burton, UK

1200 Using data to support workforce planning in Haematology
Mark Bishton, Consultant Haematologist, Nottingham University Hospitals, UK

1215 The expanding roles of Clinical Scientists
Gwyn McCreanor, Consultant Clinical Biochemist and Clinical Director, Kettering General Hospital Foundation Trust, Kettering, UK

1230 Panel discussion: How do we evolve to ensure a sustainable future pathology workforce
Join the speakers from this session for a lively debate.

1300 Lunch

Getting it Right First Time
This session will be led by the GIRFT Pathology Clinical Leads to give an outline of the programme roll-out:
1400 Cellular Pathology
Simon Knowles, Consultant Cellular Pathologist

1415 Microbiology
Tom Lewis, Consultant Microbiologist

1430 Haematology
Marion Wood, Consultant Haematologist

1445 Biochemistry
Martin Myers, Consultant Biochemist

1500 GIRFT panel discussion

1540 Break

Increased NHS Funding – what are the priorities for investment in Laboratory Medicine?
What will the government’s proposal for the NHS to receive increased funding of £20.5bn in real terms per year by the end of the 5 years mean for laboratory services?

1600 The industry perspective
Doris Ann Williams, CEO, BIVDA

1610 The Royal College of Pathologists perspective
Jo Martin, Royal College of Pathologists

1620 The Association for Clinical Biochemists perspective
Ian Young, ACB

1630 Panel discussion- Increased NHS Funding
Panel members: Doris Ann Williams, Jo Martin, Ian Young and GIRFT Leads

1710 Closing remarks
Ian Young

1730 Close

Day Two: Wednesday 30th January
Chair: Robert Michel, Editor-In-Chief, The Dark Report and President, The Dark Intelligence Group,US

0845 Welcome & opening remarks
Robert Michel, The Dark Report

0900 Laboratory Medicine – the Global Perspective
Bill Morice, President of Mayo Medical Laboratories, Departmental Chair for Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, US

0920 The Journey to Pathology 3.0
Branko Perunovic, Clinical Director Pathology

0950 Implementing the National Genomics Strategy
Mike Scott, Clinical Director, Haematopathology and Oncology Diagnostic Service, Addenbrooke’s Hospital, Cambridge, UK

1020 Personalised reference ranges; developing individualised reference ranges
Piero Rinaldo, Professor of Laboratory Medicine, Mayo Clinic, Rochester MN, US

1050 Break

How Do I Run My Core Laboratory Better?
1110 The UK Experience
Chris Charlton, Pathology Service Manager, South of Tyne and Wear Clinical Pathology Services, Clinical Support & Screening Services, Gateshead Health NHS Foundation Trust, UK

1145 The US Experience: leveraging lean to become best-in-class lab performer: how we built a new core lab while integrating lab operations and helping staff embrace a new culture.
Modena Henderson, Vice President, Laboratory Services Atrium Health Charlotte, NC,US

1220 Better commissioning for Laboratory Medicine in the NHS.
Neil Anderson, Clinical Director for Clinical Diagnostics and Chief Scientist, University Hospitals Coventry and Warwickshire NHS Trust

1245 Lunch

1400 ISO15189 as a structural support to a robust Quality Management System
Chris Allen, Quality Manager, ARUP Laboratories, Salt Lake City, US

1425 UKAS vision of ISO15189
Ben Courtney, Accreditation Manager, UK Accreditation Service (UKAS), UK

1440 Panel discussion: How do we continue the process of continuous quality improvement and maintain laboratory accreditation in the NHS?
Join the speakers for a lively debate.

Breakout Sessions
1510 Getting it Right First Time
The GIRFT panel

1510 Workforce pressures; practical solutions and advice
Gwyn McCreanor, Gerhard van Schalkwyk, Jo Martin

1510 ISO15189 and continuous quality improvement
Chris Allen, Ben Courtney

1610 Closing remarks
Robert Michel, The Dark Report

1620 FiLM Close